A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...

Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive. Despite the severity of the condition, there are ...

Compared with using stool softeners, taking lubiprostone was significantly associated with lower risks of a composite adverse kidney outcome and steeper eGFR decline. The risk for kidney function ...

Chronic Kidney Disease (CKD) signifies persistent kidney damage lasting over three months. The best indicator of kidney function is the Glomerular Filtration Rate (GFR), which measures how effectively ...

Credit: Getty Images In a 3-part series, authors discussed the neurocognitive impact of long-term medications in patients with CKD. Patients with CKD may be more susceptible to cognitive adverse drug ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure, and obesity.

STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight or obese but ...